Verona Pharma (VRNA) PT Lowered to $50 at Wedbush
Tweet
Share
E-mailGet Alerts VRNA Hot Sheet
Price: $106.91 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Wedbush analyst Liana Moussatos lowered the price target on Verona Pharma (NASDAQ: VRNA) to $50.00 (from $60.00) while maintaining a Outperform rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Korea Electric Power Corp. (015760:KS) (KEP) to Neutral
- Lenovo Group Ltd. (992:HK) (LNVGY) PT Raised to HK$45 at Nomura/Instinet
- Maxell Ltd (6810:JP) PT Raised to JPY3,100 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Liana MoussatosSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
